Form 4: Trupanion CEO Margaret Tooth Executes Stock Option and Sells Shares Under 10b5-1 Plan

Trupanion CEO Margaret Tooth exercised stock options and sold 4,000 shares of common stock on April 21, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• On April 21, 2025, Margaret Tooth, CEO of Trupanion, Inc., exercised stock options to acquire 4,000 shares of common stock at a price of $8.93 per share.
• Simultaneously, Ms. Tooth sold 4,000 shares of Trupanion common stock at a weighted average price of $33.3433 per share, with individual sales ranging from $32.7900 to $34.0400.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on November 29, 2024, for financial diversification purposes.
• Following these transactions, Ms. Tooth beneficially owns 118,784 shares of Trupanion common stock directly and holds options for 32,000 shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as the document primarily reports routine stock transactions under a pre-existing plan. No explicit positive or negative implications are apparent.

Positives

• The transactions were conducted under a pre-arranged 10b5-1 trading plan, indicating a planned and transparent approach to stock sales.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, although the use of a 10b5-1 plan mitigates this concern.

Future Outlook

The document does not contain specific forward-looking statements, but the ongoing execution of the 10b5-1 trading plan suggests continued stock sales by the CEO.

Industry Context

Executive stock transactions are common and closely monitored in the pet insurance industry, as they can reflect management's confidence in the company's prospects. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns.

Comparison to Industry Standards

• Executive compensation and stock ownership are typical metrics compared across the pet insurance industry.
• Companies like Pets Best (owned by Synchrony Financial) and Healthy Paws are also subject to similar scrutiny regarding executive stock transactions.
• The use of 10b5-1 plans is a common practice among publicly traded companies to manage executive stock sales in compliance with regulations.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, but the pre-arranged nature of the 10b5-1 plan mitigates concerns about insider trading or lack of confidence.

Key Dates

Keywords

Trupanion, Margaret Tooth, stock options, 10b5-1 plan, SEC Form 4, executive compensation, stock sale, TRUP